FP294SERUM FREE LIGHT CHAINS: A NOVEL BIOMARKER IN PRE-ECLAMPSIA (PET)
نویسندگان
چکیده
منابع مشابه
Predictive value of miR-210 as a novel biomarker for pre-eclampsia: a systematic review protocol
INTRODUCTION Pre-eclampsia (PE) is a serious condition affecting 3-5% of all pregnancies worldwide. However, underlying molecular pathogenesis of this disease has largely remained unknown. Recently, several studies have indicated the possibility role of microRNAs, especially miR-210, in the aetiology of PE. The aim of this systematic review is to assess the possible role of miR-210 as a novel b...
متن کاملEclampsia Precedes Pre-Eclampsia
Eclampsia is an extremely severe form of preeclampsia characterized by the sudden onset of generalized tonic clonic seizures. It may occur quite abruptly, without any warning manifestations. This is a case report where Mrs.X was normotensive throughout her pregnancy who underwent emergency cesarean section for cephalo pelvic disproportion and threw generalized tonic clonic seizures on the first...
متن کاملPolyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation.
C-reactive protein (CRP) is an established biomarker of acute and chronic inflammation. The hepatic synthesis of CRP is closely regulated by inflammatory cytokines, in particular interleukin-6. The CRP concentration increases rapidly in response to an inflammatory event, peaks within 48 hours, and often increases 100-fold. Bacterial infections and large burns are associated with the largest inc...
متن کاملPolyclonal free light chains: a biomarker of inflammatory disease or treatment target?
Free light chains are proteins produced by B lymphocytes during the process of antibody synthesis. Their production, as a reflection of B cell activation, can give insight into the activity of the adaptive immune system. In recent years, an automated immunoassay that provides quantitative measurement of free light chains in the serum has been developed. This assay has not only revolutionised th...
متن کاملcell free dna: a novel biomarker for clinical diagnosis
cell free dnas (cfdnas) are small fragments of genomic or mitochondrial dna releasing from cells into the blood stream. the presence of cfdna in the human circulatory system has been shown for the first time in 1948 however, the potential clinical applications of cfdna remained unknown until recent progress in detection and quantification of these molecules by sensitive methods. in this paper, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2015
ISSN: 1460-2385,0931-0509
DOI: 10.1093/ndt/gfv174.29